Collegium Pharmaceutical (STU:354) FCF Margin % : 42.35% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Collegium Pharmaceutical FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Collegium Pharmaceutical's Free Cash Flow for the three months ended in Mar. 2024 was €56.5 Mil. Collegium Pharmaceutical's Revenue for the three months ended in Mar. 2024 was €133.3 Mil. Therefore, Collegium Pharmaceutical's FCF Margin % for the quarter that ended in Mar. 2024 was 42.35%.

As of today, Collegium Pharmaceutical's current FCF Yield % is 28.88%.

The historical rank and industry rank for Collegium Pharmaceutical's FCF Margin % or its related term are showing as below:

STU:354' s FCF Margin % Range Over the Past 10 Years
Min: -4560.49 Med: 16.81 Max: 54.38
Current: 54.38

During the past 11 years, the highest FCF Margin % of Collegium Pharmaceutical was 54.38%. The lowest was -4560.49%. And the median was 16.81%.

STU:354's FCF Margin % is ranked better than
98.53% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 0.28 vs STU:354: 54.38

Collegium Pharmaceutical FCF Margin % Historical Data

The historical data trend for Collegium Pharmaceutical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Collegium Pharmaceutical FCF Margin % Chart

Collegium Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

7.19

-90.26

36.70

26.43

48.40

Collegium Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															18.99	73.53	54.10	48.87	42.35

Competitive Comparison of Collegium Pharmaceutical's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Collegium Pharmaceutical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Collegium Pharmaceutical's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Collegium Pharmaceutical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Collegium Pharmaceutical's FCF Margin % falls into.

Collegium Pharmaceutical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Collegium Pharmaceutical's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	251.522	/	519.725
	=	48.40 %

Collegium Pharmaceutical's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	56.459	/	133.329
	=	42.35 %

Collegium Pharmaceutical FCF Margin % Related Terms

Thank you for viewing the detailed overview of Collegium Pharmaceutical's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Collegium Pharmaceutical (STU:354) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Collegium Pharmaceutical Inc (STU:354) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

COLL:USA 354:Germany

Address

100 Technology Center Drive, Stoughton, MA, USA, 02072

Website

https://www.collegiumpharma.com

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol.

Collegium Pharmaceutical (STU:354) Headlines

No Headlines